{"id":992673,"date":"2026-08-10T08:16:32","date_gmt":"2026-08-10T12:16:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/"},"modified":"2026-08-10T08:16:32","modified_gmt":"2026-08-10T12:16:32","slug":"alvotech-to-report-financial-results-for-h1-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/","title":{"rendered":"Alvotech to Report Financial Results for H1 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">REYKJAVIK, Iceland, Aug.  10, 2026  (GLOBE NEWSWIRE) &#8212; Alvotech (NASDAQ: ALVO; ALVO-SDB) (the \u201cCompany\u201d), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it will release its financial results for the first half of 2026 on Wednesday, August 19, 2026, after the U.S. market close.<\/p>\n<p align=\"justify\">The Company will also host a webcast with a live Q&amp;A on Thursday, August 20, 2026, at 08:00 ET (12:00 GMT, 13:00 BST, 14:00 CEST).<\/p>\n<ul type=\"disc\">\n<li>To listen to the webcast, please register here: <a href=\"https:\/\/edge.media-server.com\/mmc\/p\/2qwpypd4\" rel=\"nofollow\" target=\"_blank\">H1 2026 webcast<\/a><\/li>\n<li>To participate in the Q&amp;A, please register here: <a href=\"https:\/\/register-conf.media-server.com\/register\/BI179b5ef63d8c4924a2076cb25acf4b15\" rel=\"nofollow\" target=\"_blank\">Q&amp;A registration<\/a><\/li>\n<\/ul>\n<p>Slides and other material will be made available on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K4ictHdI1IEna7pP1QUlMRzWNiJlnIKUyubYl9cGx9-tM8nO8YmbSfHj-IN9N1ceZkChiLwUxsLnAuUi0pmv8SMZ42rNK5oj_mS-f_TKLZsomIyiUW-ny3pneS3ACHZY\" rel=\"nofollow\" target=\"_blank\">alvotech.com\/financials<\/a> before the call.<\/p>\n<p align=\"justify\">\n        <strong>For further information, contact:<\/strong>\n      <\/p>\n<p>\n        <strong>Media<\/strong><br \/>\n        <br \/>Benedikt Stefansson<br \/>Sarah MacLeod<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K4ictHdI1IEna7pP1QUlMc9lWvymRoihxjbj81RzAH8HCIyMmlKsEs0FhIhETjma0Gs_LJs1tTZuJAyf6M06ogMTRa0vZRTj0RbQaDCap78CfPPUndpoen7c2fvkhbIE\" rel=\"nofollow\" target=\"_blank\">alvotech.media@alvotech.com<\/a><\/p>\n<p>\n        <strong>Investors<\/strong><br \/>\n        <br \/>Dr. Balaji V Prasad (US)<br \/>Benedikt Stefansson (IS)<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K4ictHdI1IEna7pP1QUlMYoWghuVOEJaSe0MJhGQo_130aSwo0i6_GgCqzBHRYsROBoHFidy90rkg-V7rr6GJADp0l6mYbm2DPhlGPz_GlwVLvQAZfkj8F7FWhxxqlP6\" rel=\"nofollow\" target=\"_blank\">alvotech.ir@alvotech.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>About Alvotech<\/strong><br \/>\n        <br \/>Alvotech is a biotechnology company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high-quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities. Five biosimilars are already approved and marketed in multiple global markets, including biosimilars to Humira\u00ae (adalimumab), Stelara\u00ae (ustekinumab), Simponi\u00ae (golimumab), Eylea\u00ae (aflibercept) and Prolia\u00ae\/Xgeva\u00ae (denosumab). The current development pipeline includes disclosed biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China and other Asian countries, and large parts of South America, Africa and the Middle East. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9Gsf0sMho9Hz6aPQoK9dAnGsbTrGTR4DnFin6rvEwHvdLfLuatwqP7MRhsKyrxBJOPJ_Bo55EfpAsnP-62p89z2IQyaT_AaSlVfkkHQ5PFg=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.alvotech.com<\/a>.<\/p>\n<p>For more information, please visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=H0gdJgFTvS8S6qJnFtJyVl_aiEznTyO3MnOjWuJKGL5H_ZSprUiW3yoJd8JQs58KfY6dBxyTA63A5hp5n9HyvQ==\" rel=\"nofollow\" target=\"_blank\">website<\/a> or follow us on social media on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xRbnU6XBAq14Rko9CRPpNE6uUXcodgvCJ5pjhGXITQ4MU7a1Ve8hGkSBYA6ir4tM2lEWKc5smsnCz_7c4Ph3R74XEDsxB7dWt-sqWouERVw=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NDLf3NluwlMrUQjTQTM20quT1cboPqRLtQYRjRadIWi72bAn5M7X8uTJ7uBrSXt1oIe5hRzM2I1nYbfMtxO7FozfYoNctw6Z-zw8xHUmC4E=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iy9pkBuG_JLHBcEOObHnx2hUru2lKNw59WL2L-QR4hupRw6otMZCsbKcijn8LIXES1Hu_ofdrgKbWJ0ImeNpWs4LLOGBiQ9WkzsMVFboyYI=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GU1xSKSFysVfZ0UuxTnGlOBPtbuyknaMSZ5kTIfd537z17WOCwbQH4eqn9Y306zfJaMcaJdM5J1tBTNqGrL3dG89vZGep4yxuma7W0bw0L0=\" rel=\"nofollow\" target=\"_blank\">YouTube<\/a>.<\/p>\n<p>None of the information on the Alvotech website shall be deemed part of this press release.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NzM0ZDg2ZGMtN2FkOS00ODM4LTllODItYjAwNzEzYmYzNzY2LTEyNDUzODYtMjAyNi0wOC0xMC1lbg==\/tiny\/Alvotech.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REYKJAVIK, Iceland, Aug. 10, 2026 (GLOBE NEWSWIRE) &#8212; Alvotech (NASDAQ: ALVO; ALVO-SDB) (the \u201cCompany\u201d), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it will release its financial results for the first half of 2026 on Wednesday, August 19, 2026, after the U.S. market close. The Company will also host a webcast with a live Q&amp;A on Thursday, August 20, 2026, at 08:00 ET (12:00 GMT, 13:00 BST, 14:00 CEST). To listen to the webcast, please register here: H1 2026 webcast To participate in the Q&amp;A, please register here: Q&amp;A registration Slides and other material will be made available on alvotech.com\/financials before the call. For further information, contact: Media Benedikt &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Alvotech to Report Financial Results for H1 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-992673","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alvotech to Report Financial Results for H1 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alvotech to Report Financial Results for H1 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REYKJAVIK, Iceland, Aug. 10, 2026 (GLOBE NEWSWIRE) &#8212; Alvotech (NASDAQ: ALVO; ALVO-SDB) (the \u201cCompany\u201d), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it will release its financial results for the first half of 2026 on Wednesday, August 19, 2026, after the U.S. market close. The Company will also host a webcast with a live Q&amp;A on Thursday, August 20, 2026, at 08:00 ET (12:00 GMT, 13:00 BST, 14:00 CEST). To listen to the webcast, please register here: H1 2026 webcast To participate in the Q&amp;A, please register here: Q&amp;A registration Slides and other material will be made available on alvotech.com\/financials before the call. For further information, contact: Media Benedikt &hellip; Continue reading &quot;Alvotech to Report Financial Results for H1 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-10T12:16:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alvotech to Report Financial Results for H1 2026\",\"datePublished\":\"2026-08-10T12:16:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/\"},\"wordCount\":327,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/\",\"name\":\"Alvotech to Report Financial Results for H1 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw==\",\"datePublished\":\"2026-08-10T12:16:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alvotech-to-report-financial-results-for-h1-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alvotech to Report Financial Results for H1 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alvotech to Report Financial Results for H1 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/","og_locale":"en_US","og_type":"article","og_title":"Alvotech to Report Financial Results for H1 2026 - Market Newsdesk","og_description":"REYKJAVIK, Iceland, Aug. 10, 2026 (GLOBE NEWSWIRE) &#8212; Alvotech (NASDAQ: ALVO; ALVO-SDB) (the \u201cCompany\u201d), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it will release its financial results for the first half of 2026 on Wednesday, August 19, 2026, after the U.S. market close. The Company will also host a webcast with a live Q&amp;A on Thursday, August 20, 2026, at 08:00 ET (12:00 GMT, 13:00 BST, 14:00 CEST). To listen to the webcast, please register here: H1 2026 webcast To participate in the Q&amp;A, please register here: Q&amp;A registration Slides and other material will be made available on alvotech.com\/financials before the call. For further information, contact: Media Benedikt &hellip; Continue reading \"Alvotech to Report Financial Results for H1 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-10T12:16:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alvotech to Report Financial Results for H1 2026","datePublished":"2026-08-10T12:16:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/"},"wordCount":327,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/","name":"Alvotech to Report Financial Results for H1 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw==","datePublished":"2026-08-10T12:16:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTI1Njg2NiM0MDI0ODU1MzQjMjIzMzgzMw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alvotech-to-report-financial-results-for-h1-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alvotech to Report Financial Results for H1 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/992673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=992673"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/992673\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=992673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=992673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=992673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}